Saffron: a promising natural medicine in the treatment of metabolic syndrome

Journal of the Science of Food and Agriculture

Volumn 97, Issue 6, 2017, Pages 1679-1685

  Razavi, Bibi Marjan ^a   Hosseinzadeh, Hossein ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cardiovascular disease; Crocus sativus L.; diabetes; dyslipidaemia; hypertension; metabolic syndrome; obesity; saffron

Indexed keywords

PLANT EXTRACT;

ANIMAL; CHEMISTRY; CROCUS; FLOWER; HUMAN; METABOLIC SYNDROME X; METABOLISM; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; CROCUS; FLOWERS; HUMANS; METABOLIC SYNDROME X; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85015149789     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.8134     Document Type: Review

References (73)

1. Galassi A, Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med 119:812–819 (2006).
2. Lakka H, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J, et al., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716 (2006).
3. Talha J and Priyanka MAA, Hypertension and herbal plants. Int Res J Pharm 2:26–30 (2011).
4. Hosseini A and Hosseinzadeh H, A review on the effects of Allium sativum (garlic) in metabolic syndrome. J Endocrinol Invest 38:1147–1157 (2015).
5. Razavi B and Hosseinzadeh H, A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome. J Endocrinol Invest 37:1031–1040 (2014).
6. Hosseinzadeh H and Nassiri-Asl M, Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J Endocrinol Invest 37:783–788 (2014).
7. Xue X, Cultivation of Crocus sativus. Zhong Yao Tong Bao 7:3 (1982).
8. Alavizadeh S and Hosseinzadeh H, Bioactivity assessment and toxicity of crocin: A comprehensive review. Food Chem Toxicol 64:65–80 (2013).
9. Selima K, Tsimidoub M and Biliaderisc C, Kinetic studies of degradation of saffron carotenoids encapsulated in amorphous polymer matrices. Food Chem 71:199–206 (2000).
10. Hosseinzadeh H and Nassiri-Asl M, Avicenna's (Ibn Sina) the canon of medicine and saffron (Crocus sativus): A review. Phytother Res 27:475–483 (2013).
11. Abdullaev FI, Biological effects of saffron. BioFactors 4:83–86 (1993).
12. Rezaee R and Hosseinzadeh H, Safranal: From an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci 16:12–26 (2013).
13. Hosseinzadeh H, Shamsaie F and Mehri S, Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L. stigma and its bioactive constituents crocin and safranal. Pharmacognet Mag 5:419–424 (2010).
14. Hosseinzadeh H and Khosravan V, Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Iran Med 5:44–77 (2002).
15. Hosseinzadeh H and Sadeghnia H, Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: Involvement of GABAergic and opioids systems. Phytomedicine 14:256–62 (2007).
16. Hosseinzadeh H, Karimi G and Niapoor M, Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. J Med Plants 3:48–58 (2004).
17. Vahdati Hassani F, Naseri V, Razavi B, Mehri S, Abnous K and Hosseinzadeh H, Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus. Daru 8:22 (2014).
18. Ghasemi T, Abnous K, Vahdati F, Mehri S, Razavi BM and Hosseinzadeh H, Antidepressant effect of Crocus sativus aqueous extract and its effect on CREB, BDNF, and VGF transcript and protein levels in rat hippocampus. Drug Res 65:337–343 (2015).
19. Amin B, Nakhsaz A and Hosseinzadeh H, Evaluation of the antidepressant-like effects of acute and sub-acute administration of crocin and crocetin in mice. Avicenna J Phytomed 5:458-4-68 (2015).
20. Hosseinzadeh H and Younesi MH, Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2:7 (2002).
21. Tamaddonfard E, Tamaddonfard S and Pourbaba S, Effects of intra-fourth ventricle injection of crocin on capsaicin-induced orofacial pain in rats. Avicenna J Phytomed 5:450–457 (2015).
22. Mahmoudabady M, Neamati A, Vosooghi S and Aghababa H, Hydroalcoholic extract of Crocus sativus effects on bronchial inflammatory cells in ovalbumin sensitized rats. Avicenna J Phytomed 3:356–363 (2013).
23. Hosseinzadeh H and Ziaei T, Effects of Crocus sativus stigma extract and its constituents, crocin and safranal, on intact memory and scopolamine-induced learning deficits in rats performing the Morris water maze task. J Med Plants 5:40–50 (2006).
24. Abe K and Saito H, Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res 14:149–152 (2000).
25. Naghibi SM, Hosseini M, Khani F, Rahimi M, Vafaee F, Rakhshandeh H et al., Effect of aqueous extract of Crocus sativus L. on morphine-induced memory impairment. Adv Pharmacol Sci 2012:494367 (2012).
26. Hosseinzadeh H and Ghenaati J, Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia 77:446–448 (2006).
27. Hosseinzadeh H and Jahanian Z, Effect of Crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother Res 24:726–730 (2010).
28. Imenshahidi M, Hosseinzadeh H and Javadpour Y, Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytother Res 24:990–994 (2010).
29. Hosseinzadeh H, Behravan J, Ramezani M and Ajgan K, Anti-tumor and cytotoxic evaluation of Crocus sativus L. stigma and petal extracts using brine shrimp and potato disc assays. J Med Plants 4:59–65 (2005).
30. Bhatti IU, Ur Rehman F, Khan MA and Marwat SK, Effect of prophetic medicine kalonji [Nigella sativa l.] on lipid profile of human beings. An in vivo approach. World Appl Sci J 6:1053–1057 (2009).
31. Shirali S, Zahra Bathaie S and Nakhjavani M, Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytother Res 27:1042–1047 (2013).
32. Mashmoul M, Azlan A, Yusof BNM, Khaza'ai H, Mohtarrudin N, Boroushaki MT et al., Effects of saffron extract and crocin on anthropometrical, nutritional and lipid profile parameters of rats fed a high fat diet. J Func Foods 8:180–187 (2014).
33. Kermani T, Mousavi SH, Shemshian M, Norouzy A, Mazidi M, Moezzi A et al., Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial. Avicenna J Phytomed 5:427–433 (2015).
34. Samarghandian S, Azimi-Nezhad M and Samini F, Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. BioMed Res Inter 2014:920857 (2014).
35. Arasteh A, Aliyev A, Khamnei S, Delazar A, Mesgari M, Mehmannavaz Y et al., Effects of hydromethanolic extract of saffron (Crocus sativus) on serum glucose, insulin and cholesterol levels in healthy male rats. J Med Plants Res 4:397–402 (2010).
36. Duval C, Müller M and Kersten S, PPARalpha and dyslipidemia. Biochim Biophys Acta 1771:961–971 (2007).
37. Mueller M, Beck V and Jungbauer A, PPARα activation by culinary herbs and spices. Planta Med 77:497–504 (2011).
38. Izadi V, Farabad E and Azadbakht L, Epidemiologic evidence on serum adiponectin level and lipid profile. Int J Prev Med 4:133–140 (2013).
39. Hemmati M, Asghari S and Zohoori E, Effects of alcoholic and aqueous extract of barberry, Jujube and saffron petals on serum level of Adiponectin and lipid profile in diabetic rats. Iran J Endocrinol Met 16:329–337 (2015).
40. Shemshiana M, Mousavi S, Norouzy A, Kermani T, Moghiman T, Sadeghi T et al., Saffron in metabolic syndrome: Its effects on antibody titers to heat-shock proteins 27, 60, 65 and 70. J Complement Integrate Med 11:43–49 (2014).
41. Guisasola MC, Dulín E, Almendral J and García-Barreno P, Reduction of heat shock protein antibody levels by statin therapy. Lipids 44:317–324 (2009).
42. Eckel R, Obesity and heart disease. Circulation 96:3248–3250 (1997).
43. Jun GK and Park CY, Anti-obesity drugs: A review about their effects and safety. Diabetes Metab J 36:13–25 (2012).
44. Gout B, Bourges C and Paineau-Dubreuil S, Satiereal, a Crocus sativus L. extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nut Res 30:305–313 (2010).
45. Kianbakht S and Dabaghian H, Anti-obesity and anorectic effects of saffron and its constituent crocin in obese Wistar rat. J Med Plants 14:25–33 (2015).
46. Askari H, Tykodi G, Liu J and Dagogo-Jack S, Fasting plasma leptin level is a surrogate measure of insulin sensitivity. J Clin Endocrinol Metab 95:3836–3843 (2010).
47. Ogihara T, Matsuzaki M, Matsuoka H, Shimamoto K, Shimada K and Rakugi H, The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: Rationale and design. Hypertens Res 28:331–338 (2005).
48. Krum H and Pellizzer AM, New and emerging drug treatments for hypertension. Aust Family Physician 27:235–237 (1998).
49. Imenshahidi M, Razavi B, Faal A, Gholampoor A, Mousavic S and Hosseinzadeh H, The effect of chronic administration of safranal on systolic blood pressure in rats. Iran J Pharm Res 14:585–590 (2015).
50. Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM and Hosseinzadeh H, The effect of chronic administration of saffron (Crocus sativus) stigma aqueous extract on systolic blood pressure in rats. Jund J Nat Pharm Prod 8:175–179 (2013).
51. Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM and Hosseinzadeh H, Effects of chronic crocin treatment on desoxycorticosterone acetate (doca)-salt hypertensive rats. Iran J Basic Med Sci 17:9–13 (2014).
52. Boskabady MH, Shafei MN, Shakiba A and Sang Sefidi H, Effect of aqueous-ethanol extract from Crocus sativus (saffron) on guinea-pig isolated heart. Phytother Res 22:330–334 (2008).
53. Mancini A, Serrano-Díaz J, Nava E, D'Alessandro A, Alonso G, Carmona M, et al., Crocetin, a carotenoid derived from saffron (Crocus sativus L.), improves acetylcholine-induced vascular relaxation in hypertension. J Vasc Res 51:393–404 (2014).
54. Razavi M, Hosseinzadeh H, Abnous K, Motamedshariaty V and Imenshahidi M, Crocin restores hypotensive effect of subchronic administration of diazinon in rats. Iran J Basic Med Sci 16:64–72 (2013).
55. Safarinejad M, Shafiei N and Safarinejad S, A prospective double-blind randomized placebo-controlled study of the effect of saffron (Crocus sativus Linn.) on semen parameters and seminal plasma antioxidant capacity in infertile men with idiopathic oligoasthenoteratozoospermia. Phytother Res 25:508–516 (2011).
56. Modaghegh M, Shahabian M, Esmaeili H, Rajbai O and Hosseinzadeh H, Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine 15:1032–1037 (2008).
57. Boskabadi MH and Aslani MR, Relaxant effect of Crocus sativus (saffron) on guinea pig tracheal chains and its possible mechanisms. J Pharm Pharmacol 58:1385–1390 (2006).
58. Laaksonen D, Lakka H, Niskanen L, Kaplan G, Salonen J and Lakka T, Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070–1077 (2002).
59. Lipscombe L and Hux J, Trend in diabetes prevalence, incidence and mortality in Ontario, Canada (1995–2005): A population-based study. Lancet 369:750–756 (2007).
60. Arasteh A, Aliyev A, Khamnei S, Delazar A, Mesgari M and Mehmannavaz Y, Effects of hydromethanolic extract of saffron (Crocus sativus) on serum glucose, insulin and cholesterol levels in healthy male rats. J Med Plants Res 4:397–402 (2010).
61. Rajaei Z, Hadjzadeh MA, Nemati H, Hosseini M, Ahmadi M and Shafiee S, Antihyperglycemic and antioxidant activity of crocin in streptozotocin-induced diabetic rats. J Med Food 16:206–210 (2013).
62. Asri-Rezaei S, Tamaddonfard E, Ghasemsoltani-Momtaz B, Erfanparast A and Gholamalipour S, Effects of crocin and zinc chloride on blood levels of zinc and metabolic and oxidative parameters in streptozotocin-induced diabetic rats. Avicenna J Phytomed 5:403–412 (2015).
63. Kianbakht S and Hajiaghaee R, Anti-hyperglycemic effects of saffron and its active constituents, crocin and safranal, in alloxan-induced diabetic rats. J Med Plants 10:82–89 (2011).
64. Mohajeri D, Mousavi G and Doustar Y, Antihyperglycemic and pancreas-protective effects of Crocus sativus L. (saffron) stigma-ethanolic extract on rats with alloxan-induced diabetes. J Biol Sci 9:302–310 (2009).
65. Kang C, Lee H, Jung E-S, Seyedian R, Jo M, Kim J et al., Saffron (Crocus sativus L.) increases glucose uptake and insulin sensitivity in muscle cells via multipathway mechanisms. Food Chem 135:2350–2358 (2012).
66. Maeda A, Kai K, Ishii M, Ishii T and Akagava M, Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice. Mol Nut Food Res 58:1177–1189 (2014).
67. Xi L, Qian Z, Xu G, Zheng S, Sun S, Wen N et al., Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J Nutr Biochem 18:64–72 (2007).
68. Grisolia S, Letter: Hypoxia, saffron, and cardiovascular disease. Lancet 6:41–42 (1974).
69. Altinoz E, Oner Z, Elbe H, Cigremis Y and Turkoz Y, Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats. Hum Exp Toxicol 34:127–134 (2015).
70. Mousavi SH, Tayarani NZ and Parsaee H, Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in pc12 cells. Cell Mol Neurobiol 30:185–191 (2010).
71. Rahbani M, Mohajeri D, Rezaie A and Nazeri M, Protective effect of ethanolic extract of saffron (dried stigmas of Crocus sativus L.) on hepatic tissue injury in streptozotocin-induced diabetic rats. J Anim Vet Adv 11:1985–1994 (2012).
72. Farshid AA and Tamaddonfard E, Histopathological and behavioral evaluations of the effects of crocin, safranal and insulin on diabetic peripheral neuropathy in rats. Avicenna J Phytomed 5:469–478 (2015).
73. Hazman O and Ovali S, Investigation of the anti-inflammatory effects of safranal on high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Inflammation 38:1012–1019 (2014).